Ginsengenin derivatives synthesized from 20(R)-panaxotriol: Synthesis, characterization, and antitumor activity targeting HIF-1 pathway

Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322/caac.20107 Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, 136, E359, 10.1002/ijc.29210 Hait, 2010, Anticancer drug development: the grand challenges, Nat Rev Drug Discov, 9, 253, 10.1038/nrd3144 Arbyn, 2020, Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis, Lancet Global Health, 8, e191, 10.1016/S2214-109X(19)30482-6 Powis, 2004, Hypoxia inducible factor-1alpha as a cancer drug target, Mol Cancer Ther, 3, 647, 10.1158/1535-7163.647.3.5 Vaupel, 2004, Tumor hypoxia and malignant progression, Methods Enzymol, 381, 335, 10.1016/S0076-6879(04)81023-1 Semenza, 2010, Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics, Oncogene, 29, 625, 10.1038/onc.2009.441 Ke, 2006, Hypoxia-inducible factor-1 (HIF-1), Mol Pharmacol, 70, 1469, 10.1124/mol.106.027029 Semenza, 2003, Targeting HIF-1 for cancer therapy, Nat Rev Cancer, 3, 721, 10.1038/nrc1187 Pientka, 2012, Oxygen sensing by the prolyl-4-hydroxylase PHD2 within the nuclear compartment and the influence of compartmentalisation on HIF-1 signalling, J Cell Sci, 25, 5168 Li, 2017, Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1alpha signaling, Chem Biol Interact, 274, 58, 10.1016/j.cbi.2017.06.029 Lu, 2019, Downregulation of RGMA by HIF-1A/miR-210-3p axis promotes cell proliferation in oral squamous cell carcinoma, Biochem Pharmacol, 112, 108608 Yao, 2018, Combinatorial treatment of Rhizoma Paridis saponins and sorafenib overcomes the intolerance of sorafenib, J Steroid Biochem Mol Biol, 183, 159, 10.1016/j.jsbmb.2018.06.010 Zhu, 2019, Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype, J Exp Clin Cancer Res, 38, 81, 10.1186/s13046-019-1095-1 Choi, 2015, Molecular targeted therapy for hepatocellular carcinoma: present status and future directions, Biol Pharm Bull, 38, 986, 10.1248/bpb.b15-00231 Wu, 2012, Targeted therapy: its status and promise in selected solid tumors part I: areas of major impact, Oncology (Williston Park), 26, 936 Hodges, 2004, Molecular-targeted antitumor agents: the Saururus cernuus dineolignans manassantin B and 4-O-demethylmanassantin B are potent inhibitors of hypoxia-activated HIF-1, J Nat Prod, 67, 767, 10.1021/np030514m Yuan, 2015, Potential cardioprotective effects of Ginseng preparations, Pak J Pharm Sci, 28, 963 Attele, 1999, Ginseng pharmacology, Biochem Pharmacol, 58, 1685, 10.1016/S0006-2952(99)00212-9 Kim, 2018, Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases, J Ginseng Res, 42, 264, 10.1016/j.jgr.2017.10.004 Shibata, 2001, Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds, J Kor Med Sci, 16, S28, 10.3346/jkms.2001.16.S.S28 Park, 2005, Biological activities and chemistry of saponins from Panax ginseng C, A. Meyer. Phytochem Rev, 4, 159, 10.1007/s11101-005-2835-8 Wei, 2009, Anti-HIV protease triterpenoids from the acid hydrolysate of Panax ginseng, Phytochem Lett, 2, 63, 10.1016/j.phytol.2008.12.001 Yu, 2018, Potential antitumor effects of panaxatriol against DU-15 human prostate cancer cells is mediated via mitochondrial mediated apoptosis, inhibition of cell migration and sub-G1 cell cycle arrest, J Buon, 23, 200 Li, 2019, Biotransformation of 20(R)-panaxatriol by the fungus Aspergillus flavus link AS 3.3950, Nat Prod Res, 33, 1393, 10.1080/14786419.2017.1416380 Sheng, 2011, New lead structures in antifungal drug discovery, Curr Med Chem, 18, 733, 10.2174/092986711794480113 Neu, 1979, Cefatrizine activity compared with that of other cephalosporins, Antimicrob Agents Chemother, 15, 209, 10.1128/AAC.15.2.209 Soltis, 1996, Identification and characterization of human metabolites of CAI [5-amino-1-1(4'-chlorobenzoyl-3,5-dichlorobenzyl)-1,2,3-triazole- 4-carboxamide), Drug Metab Dispos, 24, 799 Higashitani, 1990, Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin, J Antimicrob Chemother, 25, 567, 10.1093/jac/25.4.567 Zhang, 2018, Synthesis and evaluation of the anticonvulsant activities of new 5-substitued-[1,2,4]triazolo[4,3-a]quinoxalin-4(5H)-one derivatives, Lett Drug Des Discov, 15, 406, 10.2174/1570180814666170619094408 Liu, 2017, Synthesis and evaluation of the anticonvulsant activities of 2,3-dihydrophthalazine-1,4-dione derivatives, Med Chem Res, 26, 1935, 10.1007/s00044-017-1896-8 Ren, 2016, Synthesis and anticonvulsant activities of 4-Alkoxyl-[1,2,4]Triazolo[4,3-a]Quinoxaline derivatives, Lat Am J Pharm, 35, 2169 Liu, 2016, Synthesis and anticonvulsant activity of novel 3-(2-(4H-1,2,4-triazol-4-yl)ethyl)-1-alkyl-1H-indole derivatives, Lett Drug Des Discov, 13, 833, 10.2174/1570180813666160324173717 Zhang, 2016, Design, synthesis, and evaluation of the anticonvulsant and antidepressant activities of pyrido[2,3-d]pyrimidine derivatives, Med Chem Res, 25, 1287, 10.1007/s00044-016-1559-1 Pang, 2020, Synthesis, in vitro and in vivo biological evaluation of novel lappaconitine derivatives as potential anti-inflammatory agents, Acta Pharm Sin B, 10, 628, 10.1016/j.apsb.2019.09.002 Pan, 2015, Synthesis of 4-Phenylthieno[2,3-e][1,2,4]triazolo[4,3-a]pyrimidine-5(4H)-one derivatives and evaluation of their anti-inflammatory activity, Lett Drug Des Dis, 13, 141, 10.2174/1570180812666150630184439 Zhang, 2016, Synthesis and antimicrobial evaluation of aminoguanidine and 3-amino- 1,2,4-triazole derivatives as potential antibacterial agents, Lett Drug Des Dis, 13, 1063, 10.2174/1570180813666160819151239 Zhang, 2017, Synthesis and characterisation of celastrol derivatives as potential anticancer agents, J Enzyme Inhib Med Chem, 33, 190, 10.1080/14756366.2017.1404590 Shen, 2019, Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: a novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway, Eur J Med Chem, 173, 15, 10.1016/j.ejmech.2019.04.005 Luan, 2018, Design and synthesis of C-19 isosteviol derivatives as potent and highly selective antiproliferative agents, Molecules, 24, 121, 10.3390/molecules24010121 De, 2011, Cinnamic acid derivatives as anticancer agents-a review, Curr Med Chem, 18, 1672, 10.2174/092986711795471347 Li, 2008, Anticancer effects of ginsenoside Rg1, cinnamic acid, and tanshinone IIA in osteosarcoma MG-63 cells: nuclear matrix downregulation and cytoplasmic trafficking of nucleophosmin, Int J Biochem Cell Biol, 40, 1918, 10.1016/j.biocel.2008.01.031 Ghosh, 2015, Organic carbamates in drug design and medicinal chemistry, J Med Chem, 58, 2895, 10.1021/jm501371s Kamal, 2011, Synthesis of 4beta-carbamoyl epipodophyllotoxins as potential antitumour agents, Bioorg Med Chem, 19, 2975, 10.1016/j.bmc.2011.03.030 Liu, 2011, Synthesis and anti-tumor evaluation of panaxadiol derivatives, Eur J Med Chem, 46, 1997, 10.1016/j.ejmech.2011.02.022 Wang, 2020, Panaxadiol inhibits programmed cell death-ligand 1 expression and tumour proliferation via hypoxia-inducible factor (HIF)-1alpha and STAT3 in human colon cancer cells, Pharmacol Res, 155, 10.1016/j.phrs.2020.104727 Fan, 2020, Curcumin, as a pleiotropic agent, improves doxorubicin-induced nephrotic syndrome in rats, J Ethnopharmacol, 250, 10.1016/j.jep.2019.112502 Yang, 2018, H6, a novel hederagenin derivative, reverses multidrug resistance in vitro and in vivo, Toxicol Appl Pharmacol, 341, 98, 10.1016/j.taap.2018.01.015 Jin, 2012, Cryptopleurine targets NF-kappaB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis, PLoS One, 7 Dai, 2015, Synthesis and antifungal activity of 1,2,3-triazole phenylhydrazone derivatives, Org Biomol Chem, 13, 477, 10.1039/C4OB01758G Jia, 2010, 'Click' assembly of selective inhibitors for MAO-A, Bioorg Med Chem Lett, 20, 6222, 10.1016/j.bmcl.2010.08.104 Meldal, 2008, Cu-catalyzed azide-alkyne cycloaddition, Chem Rev, 108, 2952, 10.1021/cr0783479 Abdel-Atty, 2014, Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as Histone Deacetylase inhibitors and cytotoxic agents, Bioorg Chem, 57, 65, 10.1016/j.bioorg.2014.08.006 Wilson, 2011, Targeting hypoxia in cancer therapy, Nat Rev Cancer, 11, 393, 10.1038/nrc3064 Lei, 2015, Impedimetric quantification of the formation process and the chemosensitivity of cancer cell colonies suspended in 3D environment, Biosens Bioelectron, 74, 878, 10.1016/j.bios.2015.07.060 Zhou, 2016, TUFT1 regulates metastasis of pancreatic cancer through HIF1-Snail pathway induced epithelial-mesenchymal transition, Cancer Lett, 382, 11, 10.1016/j.canlet.2016.08.017 Umezu, 2014, Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1, Blood, 124, 3748, 10.1182/blood-2014-05-576116